In Memoriam: The Company was deeply saddened to learn of Mr. Chris van Ingen’s passing on June 27, 2017.

Mr. van Ingen served on the Company’s Board from 2012 to June 2017, and as a director of Bruker Energy & Supercon Technologies, Inc., a wholly-owned subsidiary of the Company, from 2009 to 2013. The Company’s Board and management are extremely grateful for Mr. van Ingen’s guidance and leadership over the years and extend their deepest condolences to his... Read more

Thermo Fisher Scientific Adds Three New Products to Leading Semiconductor Portfolio

New products designed to help semiconductor failure analysis labs achieve higher volumes of samples and faster time-to-data HILLSBORO, Ore., June 29, 2017 /PRNewswire/ — For semiconductor manufacturers seeking fast, high-quality electrical and physical failure analysis, Thermo Fisher Scientific today announced three new additions to its broad portfolio of semiconductor failure analysis workflows. The company will demonstrate these products and... Read more

Illumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer from the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology... Read more

Thermo Fisher Scientific Announces Availability of Two New Immunoassays Designed to Maximize Detection of Synthetic Cannabinoids

FREMONT, Calif., June 28, 2017 /PRNewswire/ — Two new immunoassays for the detection of Synthetic Cannabinoids, the Thermo Fisher CEDIA AB-PINACA and CEDIA UR-144/XLR11 Assays are now available for Criminal Justice and Forensic Use.  Synthetic Cannabinoids are the largest and fastest growing group of new psychoactive substances on the market, making the availability of these assays... Read more

MilliporeSigma Wins False Advertising Lawsuit Against Distributor of RephiLe Bioscience Lab Water Products

June 27, 2017 MilliporeSigma Wins False Advertising Lawsuit Against Distributor of RephiLe Bioscience Lab Water Products Analis S.A. ordered to cease all illegal advertising following MilliporeSigma lawsuit Belgian distributor claimed RephiLe Bioscience’s lab water purification products were equivalent to MilliporeSigma’s Analis’ advertisements found misleading by Belgian court MilliporeSigma, a leading science and technology company, today... Read more

New Enrichment Media Formats Offer Reduced Preparation Time to Food Microbiology Laboratories

Thermo_Fisher_Scientific_Logo Thermo Fisher Scientific QuickBag, 4.5L Thermo Fisher Scientific FitBag 4.5L Help streamline media preparation workflows and increase productivity BASINGSTOKE, England, June 27, 2017 /PRNewswire/ — To facilitate operational efficiency in food microbiology laboratories, a new range of bagged enrichment media is designed to reduce hands-on preparation time. The bags contain pre-weighed, ready-to-hydrate, gamma-irradiated enrichment media... Read more

Bruker Announces Novel NMR Phenomics Research Capabilities

BRISBANE, Australia, June 26, 2017 /PRNewswire/ — At the Metabolomics Society Meeting 2017, Bruker announces a new solution for the quantification of metabolites in urine using Nuclear Magnetic Resonance (NMR). Urine metabolic analysis is particularly valuable and information-rich, because the metabolic pathways of a wide range of nutrients, drugs and environmental contaminants can be identified in urine,... Read more

Genomics England Adopts Illumina’s BaseSpace Variant Interpreter for Cancer

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) and Genomics England announced today that Illumina is the primary variant interpretation and reporting software vendor for tumor and matched normal samples characterized as part of the 100,000 Genomes Project. In a little over a year since Illumina announced the Bioinformatics and Clinical Interpretation Partnership with Genomics England, the partnership has now set... Read more

Waters Corporation Elects Flemming Ornskov to Board of Directors

June 22, 2017 04:30 AM Pacific Daylight Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE: WAT) today announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today. “It is an honor to welcome Flemming Ornskov to our Board of Directors,” said Christopher J. O’Connell, Waters Corporation President... Read more